Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid

Billie Bixby,Lukas Vrba,Jyoti Lenka,Marc M. Oshiro,George S. Watts,Trina. Hughes,Heidi Erickson,Madhav Chopra,James L. Knepler,Kenneth S. Knox,Lisa Jarnagin,Raed Alalawi,Mrinalini Kala,Richard Bernert,Joshua Routh,Denise J. Roe,Linda L. Garland,Bernard W. Futscher,Mark A. Nelson

DOI: https://doi.org/10.1038/s41598-024-53132-x

IF: 4.6

2024-02-06

Scientific Reports

Abstract:Diagnosis of malignant pleural effusion (MPE) is made by cytological examination of pleural fluid or histological examination of pleural tissue from biopsy. Unfortunately, detection of malignancy using cytology has an overall sensitivity of 50%, and is dependent upon tumor load, volume of fluid assessed, and cytopathologist experience. The diagnostic yield of pleural fluid cytology is also compromised by low abundance of tumor cells or when morphology is obscured by inflammation or reactive mesothelial cells. A reliable molecular marker that may complement fluid cytology for the diagnosis of malignant pleural effusion is needed. The purpose of this study was to establish a molecular diagnostic approach based on pleural effusion cell-free DNA methylation analysis for the differential diagnosis of malignant pleural effusion and benign pleural effusion. This was a blind, prospective case–control biomarker study. We recruited 104 patients with pleural effusion for the study. We collected pleural fluid from patients with: MPE (n = 48), indeterminate pleural effusion in subjects with known malignancy or IPE (n = 28), and benign PE (n = 28), and performed the Sentinel-MPE liquid biopsy assay. The methylation level of Sentinel-MPE was markedly higher in the MPE samples compared to BPE control samples ( p < 0.0001) and the same tendency was observed relative to IPE ( p = 0.004). We also noted that the methylation signal was significantly higher in IPE relative to BPE ( p < 0.001). We also assessed the diagnostic efficiency of the Sentinel-MPE test by performing receiver operating characteristic analysis (ROC). For the ROC analysis we combined the malignant and indeterminate pleural effusion groups (n = 76) and compared against the benign group (n = 28). The detection sensitivity and specificity of the Sentinel-MPE test was high (AUC = 0.912). The Sentinel-MPE appears to have better performance characteristics than cytology analysis. However, combining Sentinel-MPE with cytology analysis could be an even more effective approach for the diagnosis of MPE. The Sentinel-MPE test can discriminate between BPE and MPE. The Sentinel-MPE liquid biopsy test can detect aberrant DNA in several different tumor types. The Sentinel-MPE test can be a complementary tool to cytology in the diagnosis of MPE.

multidisciplinary sciences

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to improve the diagnostic accuracy of malignant pleural effusion (MPE). Currently, the sensitivity of detecting malignant tumors by cytological examination of pleural effusion is only 50%, and it is affected by factors such as tumor burden, the amount of fluid evaluated, and the experience of cytopathologists. In addition, when the number of tumor cells is small or when inflammation or reactive mesothelial cells affect the morphology, the diagnostic effect of cytological examination will be further affected. Therefore, researchers hope to find a reliable molecular marker that can supplement cytological examination to improve the diagnostic accuracy of MPE.

To achieve this goal, the researchers developed a new liquid biopsy method based on cell - free DNA (cfDNA) methylation analysis of pleural effusion - Sentinel - MPE. This method aims to distinguish malignant pleural effusion from benign pleural effusion (BPE) by detecting the DNA methylation levels at specific genomic loci, thereby assisting in the diagnosis of MPE. The study recruited 104 patients with pleural effusion, including MPE patients, patients with pleural effusion of undetermined nature (IPE) patients and BPE patients, through a prospective case - control study design. The Sentinel - MPE liquid biopsy test was carried out and compared with the results of traditional cytological examinations to evaluate its diagnostic efficacy. The research results show that Sentinel - MPE has shown high sensitivity and specificity in distinguishing MPE from BPE, especially when combined with cytological examination, the diagnostic efficacy is further improved. This indicates that Sentinel - MPE can be used as an effective supplementary tool for cytological examination to improve the early diagnosis rate of MPE.